Is Flora Growth Corp. technically bullish or bearish?
2025-09-20 20:05:05As of 11 September 2025, the technical trend for Flora Growth Corp. has changed from mildly bullish to bullish. The current stance is bullish, albeit with some mixed signals across different indicators. The MACD is mildly bullish on both weekly and monthly time frames, while the Dow Theory also supports a mildly bullish outlook in both periods. However, the moving averages indicate a mildly bearish trend on the daily chart, and the KST is bearish on both weekly and monthly time frames. The Bollinger Bands show a bullish signal weekly but are mildly bearish monthly. In terms of performance, Flora Growth Corp. has outperformed the S&P 500 over the past week and month, with returns of 8.28% and 10.27% respectively, while it has significantly underperformed year-to-date and over the past year, with returns of -35.85% and -37.07%. Overall, the technical indicators suggest a bullish sentiment, but caution is wa...
Read MoreIs Flora Growth Corp. overvalued or undervalued?
2025-09-20 18:38:01As of 9 August 2022, Flora Growth Corp. has moved from a grade of "does not qualify" to "risky." The company appears to be overvalued based on its current financial metrics. Key ratios include a Price to Book Value of 3.04, an EV to Sales ratio of 0.30, and a troubling ROCE of -218.48%. In comparison to its peers, Flora Growth Corp. has a significantly negative EV to EBITDA ratio of -1.25, while Upexi, Inc. shows a worse EV to EBITDA of -37.9754, and ProPhase Labs, Inc. has a less negative EV to EBITDA of -1.6442. Despite a recent positive stock return of 10.27% over the past month compared to the S&P 500's 2.33%, the year-to-date return of -35.85% against the S&P's 12.22% indicates ongoing struggles for the company....
Read More
Flora Growth Corp. Hits New 52-Week High of $25.70, Surging 2108.7%
2025-09-16 11:34:28Flora Growth Corp., a microcap in the Pharmaceuticals & Biotechnology sector, achieved a new 52-week high of USD 25.70 on September 15, 2025, reflecting a significant stock performance increase over the past year. Despite this, the company operates at a loss with negative return on equity and no dividend yield.
Read More





